Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia - Wierda, WG; Kipps, TJ; Mayer, J (J Clin Oncol Off J Am Soc Clin Oncol, 2010)
et al.